M Alfishawy1,2, A Elbendary3, M Mohamed4, M Nassar5. 1. Infectious Diseases Consultants and Academic Researchers of Egypt (IDCARE), Cairo, Egypt. 2. Aswan Heart Centre, Aswan, Egypt. 3. Dermatology Department, Kasr Alainy Faculty of Medicine, Cairo University, Cairo, Egypt. 4. Nephrology Division, University of Tennessee Health Science Center, Memphis, TN, USA. 5. Internal Medicine Department, Beni Suef University, Beni Suef, Egypt.
Abstract
BACKGROUND: Organ transplant recipients are vulnerable to multiple infectious agents and in a world with a circulating SARS-CoV-2 virus, it would be expected that patients who are immunosuppressed would have higher mortality. OBJECTIVE: To determine the COVID-19 mortality in transplant recipients. METHODS: We conducted a search in PubMed and Google scholar databases using the keywords for COVID-19 and transplantation. All related studies between January 1, 2020 and May 7, 2020 were reviewed. All relevant published articles related to COVID-19 in transplant recipients were included. RESULTS: 46 articles were included; they studied a total of 320 transplant patients-220 kidney transplant recipients, 42 liver, 19 heart, 22 lung, 8 HSCT, and 9 dual organ transplant recipients. The overall mortality rate was 20% and was variable among different organs and different countries. 65 transplant recipients died of complications attributable to COVID-19; 33 were males (15% of males in this cohort), 8 females (8% of females in this cohort), and 24 whose sex was not determined. They had a median age of 66 (range: 32-87) years. The median transplantation duration was 8 years (range: 30 days to 20 years). The most frequent comorbidity reported was hypertensions followed by diabetes mellitus, obesity, malignancy, ischemic heart disease, and chronic obstructive pulmonary disease. The most frequent cause of death reported was acute respiratory distress syndrome. CONCLUSION: Transplant recipients in our cohort had a high mortality rate. However, outcomes were not the same in different countries based on outbreak settings. Mortality was noted in elder patients with comorbidities.
BACKGROUND: Organ transplant recipients are vulnerable to multiple infectious agents and in a world with a circulating SARS-CoV-2 virus, it would be expected that patients who are immunosuppressed would have higher mortality. OBJECTIVE: To determine the COVID-19 mortality in transplant recipients. METHODS: We conducted a search in PubMed and Google scholar databases using the keywords for COVID-19 and transplantation. All related studies between January 1, 2020 and May 7, 2020 were reviewed. All relevant published articles related to COVID-19 in transplant recipients were included. RESULTS: 46 articles were included; they studied a total of 320 transplant patients-220 kidney transplant recipients, 42 liver, 19 heart, 22 lung, 8 HSCT, and 9 dual organ transplant recipients. The overall mortality rate was 20% and was variable among different organs and different countries. 65 transplant recipients died of complications attributable to COVID-19; 33 were males (15% of males in this cohort), 8 females (8% of females in this cohort), and 24 whose sex was not determined. They had a median age of 66 (range: 32-87) years. The median transplantation duration was 8 years (range: 30 days to 20 years). The most frequent comorbidity reported was hypertensions followed by diabetes mellitus, obesity, malignancy, ischemic heart disease, and chronic obstructive pulmonary disease. The most frequent cause of death reported was acute respiratory distress syndrome. CONCLUSION: Transplant recipients in our cohort had a high mortality rate. However, outcomes were not the same in different countries based on outbreak settings. Mortality was noted in elder patients with comorbidities.
Authors: Enver Akalin; Yorg Azzi; Rachel Bartash; Harish Seethamraju; Michael Parides; Vagish Hemmige; Michael Ross; Stefanie Forest; Yitz D Goldstein; Maria Ajaimy; Luz Liriano-Ward; Cindy Pynadath; Pablo Loarte-Campos; Purna B Nandigam; Jay Graham; Marie Le; Juan Rocca; Milan Kinkhabwala Journal: N Engl J Med Date: 2020-04-24 Impact factor: 91.245
Authors: Muhammad Baraa Hammami; Brian Garibaldi; Pali Shah; Gigi Liu; Tania Jain; Po-Hung Chen; Amy K Kim; Edina Avdic; Brent Petty; Sara Strout; Derek M Fine; Ashwini Niranjan-Azadi; William M Garneau; Andrew M Cameron; Jose M Monroy Trujillo; Ahmet Gurakar; Robin Avery Journal: Am J Transplant Date: 2020-06-03 Impact factor: 9.369
Authors: Ilaria Gandolfini; Marco Delsante; Enrico Fiaccadori; Gianluigi Zaza; Lucio Manenti; Anna Degli Antoni; Licia Peruzzi; Leonardo V Riella; Paolo Cravedi; Umberto Maggiore Journal: Am J Transplant Date: 2020-04-12 Impact factor: 8.086
Authors: Marzuq Billah; Andrew Santeusanio; Veronica Delaney; Paolo Cravedi; Samira S Farouk Journal: Transpl Int Date: 2020-05-18 Impact factor: 3.842
Authors: Olivia S Kates; Cynthia E Fisher; Helen C Stankiewicz-Karita; Amanda K Shepherd; E Chandler Church; Siddhartha G Kapnadak; Erika D Lease; Francis X Riedo; Robert M Rakita; Ajit P Limaye Journal: Am J Transplant Date: 2020-05-08 Impact factor: 9.369
Authors: Elena Guillen; Gaston J Pineiro; Ignacio Revuelta; Diana Rodriguez; Marta Bodro; Asunción Moreno; Josep M Campistol; Fritz Diekmann; Pedro Ventura-Aguiar Journal: Am J Transplant Date: 2020-04-09 Impact factor: 9.369
Authors: Maria Guarino; Valentina Cossiga; Ilaria Loperto; Ilaria Esposito; Rosanna Ortolani; Andrea Fiorentino; Giuseppina Pontillo; Lucia De Coppi; Valentina Cozza; Alfonso Galeota Lanza; Giovanni Giuseppe Di Costanzo; Francesco Paolo Picciotto; Filomena Morisco Journal: Sci Rep Date: 2022-03-22 Impact factor: 4.379